Iqvia Holdings (IQV) Free Cash Flow Growth (3y) (2015 - 2026)
Iqvia Holdings (IQV) Free Cash Flow Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn | 10.07% |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn | -10.05% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 23.11% |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn | -16.15% |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn | 14.16% |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | 30.41% |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn | 40.54% |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn | 5.89% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 10.52% |
| 10 | Labcorp Holdings | 25.90 Bn | 24.92 Bn | 1.01 Bn | 17.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.16% |
| Mar 31, 2026 | 24.73% |
| Dec 31, 2025 | 12.98% |
| Sep 30, 2025 | 3.42% |
| Jun 30, 2025 | 20.23% |
| Mar 31, 2025 | 8.77% |
| Dec 31, 2024 | 12.38% |
| Sep 30, 2024 | -5.75% |
| Jun 30, 2024 | 4.14% |
| Mar 31, 2024 | -19.33% |
| Dec 31, 2023 | -0.35% |
| Sep 30, 2023 | 1.57% |
| Jun 30, 2023 | -9.82% |
| Mar 31, 2023 | 125.72% |
| Dec 31, 2022 | -4.46% |
| Sep 30, 2022 | 56.82% |
| Jun 30, 2022 | -10.71% |
| Mar 31, 2022 | 139.99% |
| Dec 31, 2021 | 22.11% |
| Sep 30, 2021 | 45.59% |